Metabolic reprogramming in osteoclasts

被引:0
|
作者
Kyung-Hyun Park-Min
机构
[1] Hospital for Special Surgery,Arthritis and Tissue Degeneration Program, David Z. Rosensweig Genomics Research Center
[2] Weill Cornell Medical College,Department of Medicine
[3] Weill Cornell Graduate School of Medical Sciences,BCMB Allied Program
来源
关键词
Osteoclasts; Metabolism; Metabolic reprogramming;
D O I
暂无
中图分类号
学科分类号
摘要
Osteoclasts are bone-resorbing cells that play an essential role in the remodeling of the bone. Defects in osteoclasts thus result in unbalanced bone remodeling, leading to numerous pathological conditions such as osteoporosis, bone metastasis, and inflammatory bone erosion. Metabolism is any process a cell utilizes to meet its energetic demand for biological functions. Along with signaling pathways and osteoclast-specific gene expression programs, osteoclast differentiation activates metabolic programs. The energy generated from metabolic reprogramming in osteoclasts not only supports the phenotypic changes from mononuclear precursor cells to multinuclear osteoclasts, but also facilitates bone resorption, a major function of terminally differentiated, mature osteoclasts. While oxidative phosphorylation is studied as a major metabolic pathway that fulfills the energy demands of osteoclasts, all metabolic pathways are closely interconnected. Therefore, it remains important to understand the various aspects of osteoclast metabolism, including the roles and effects of glycolysis, glutaminolysis, fatty acid synthesis, and fatty acid oxidation. Targeting the pathways associated with metabolic reprogramming has shown beneficial effects on pathological conditions. As a result, it is clear that a deeper understanding of metabolic regulation in osteoclasts will offer broader translational potential for the treatment of human bone disorders.
引用
收藏
页码:565 / 572
页数:7
相关论文
共 50 条
  • [41] Glucose is a key metabolic regulator of osteoclasts.
    Larsen, LI
    Sekar, MC
    Thames, AM
    Williams, JP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S248 - S248
  • [42] Metabolic reprogramming and interventions in endometrial carcinoma
    Li, Jiajia
    Yang, Hongmei
    Zhang, Lingyi
    Zhang, Songling
    Dai, Yun
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [43] Nitric oxide and tumor metabolic reprogramming
    Lopez-Sanchez, Laura M.
    Aranda, Enrique
    Rodriguez-Ariza, Antonio
    [J]. BIOCHEMICAL PHARMACOLOGY, 2020, 176
  • [44] Metabolic reprogramming and kidney cancer progression
    DeBerardinis, Ralph J.
    [J]. CANCER RESEARCH, 2023, 83 (16)
  • [45] Metabolic reprogramming in response to cell mechanics
    Splitt, Rebecca L.
    DeMali, Kris A.
    [J]. BIOLOGY OF THE CELL, 2023, 115 (05)
  • [46] Glutamine metabolic reprogramming in hepatocellular carcinoma
    Ye, Yanyan
    Yu, Bodong
    Wang, Hua
    Yi, Fengming
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [47] Lipid metabolic reprogramming in cancer cells
    Beloribi-Djefaflia, S.
    Vasseur, S.
    Guillaumond, F.
    [J]. ONCOGENESIS, 2016, 5 : e189 - e189
  • [48] TORquing metabolic reprogramming in cancer cells
    Pusapati, Raju
    Settleman, Jeff
    [J]. CELL CYCLE, 2016, 15 (18) : 2387 - 2388
  • [49] Oncogenic regulation of tumor metabolic reprogramming
    Tarrado-Castellarnau, Miriam
    de Atauri, Pedro
    Cascante, Marta
    [J]. ONCOTARGET, 2016, 7 (38) : 62726 - 62753
  • [50] The cancer metabolic reprogramming and immune response
    Xia, Longzheng
    Oyang, Linda
    Lin, Jinguan
    Tan, Shiming
    Han, Yaqian
    Wu, Nayiyuan
    Yi, Pin
    Tang, Lu
    Pan, Qing
    Rao, Shan
    Liang, Jiaxin
    Tang, Yanyan
    Su, Min
    Luo, Xia
    Yang, Yiqing
    Shi, Yingrui
    Wang, Hui
    Zhou, Yujuan
    Liao, Qianjin
    [J]. MOLECULAR CANCER, 2021, 20 (01)